[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE8703343L - Derivat av 2,3,4,5,6,7-hexahydro-2,7-metano-1,5-bensoxazonin (resp -1,4-bensoxazonin), forfarande for framstellning derav och lekemedel, som innehaller denna forening - Google Patents

Derivat av 2,3,4,5,6,7-hexahydro-2,7-metano-1,5-bensoxazonin (resp -1,4-bensoxazonin), forfarande for framstellning derav och lekemedel, som innehaller denna forening

Info

Publication number
SE8703343L
SE8703343L SE8703343A SE8703343A SE8703343L SE 8703343 L SE8703343 L SE 8703343L SE 8703343 A SE8703343 A SE 8703343A SE 8703343 A SE8703343 A SE 8703343A SE 8703343 L SE8703343 L SE 8703343L
Authority
SE
Sweden
Prior art keywords
benzoxazonin
hexahydro
metano
resp
derivatives
Prior art date
Application number
SE8703343A
Other languages
English (en)
Swedish (sv)
Other versions
SE8703343D0 (sv
Inventor
F Eiden
P Gmeiner
J Schunemann
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of SE8703343D0 publication Critical patent/SE8703343D0/xx
Publication of SE8703343L publication Critical patent/SE8703343L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8703343A 1986-09-08 1987-08-28 Derivat av 2,3,4,5,6,7-hexahydro-2,7-metano-1,5-bensoxazonin (resp -1,4-bensoxazonin), forfarande for framstellning derav och lekemedel, som innehaller denna forening SE8703343L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863630539 DE3630539A1 (de) 1986-09-08 1986-09-08 Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Publications (2)

Publication Number Publication Date
SE8703343D0 SE8703343D0 (sv) 1987-08-28
SE8703343L true SE8703343L (sv) 1988-03-09

Family

ID=6309142

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703343A SE8703343L (sv) 1986-09-08 1987-08-28 Derivat av 2,3,4,5,6,7-hexahydro-2,7-metano-1,5-bensoxazonin (resp -1,4-bensoxazonin), forfarande for framstellning derav och lekemedel, som innehaller denna forening

Country Status (29)

Country Link
US (1) US4859664A (xx)
JP (1) JPS6377882A (xx)
KR (1) KR910002566B1 (xx)
CN (1) CN1020103C (xx)
AR (1) AR243190A1 (xx)
AT (1) ATA185987A (xx)
AU (1) AU590443B2 (xx)
BE (1) BE1002121A4 (xx)
CH (1) CH675723A5 (xx)
CS (1) CS621687A2 (xx)
DD (1) DD275052A1 (xx)
DE (1) DE3630539A1 (xx)
DK (1) DK464487A (xx)
ES (1) ES2013322A6 (xx)
FI (1) FI88800C (xx)
FR (1) FR2603587B1 (xx)
GB (1) GB2194786B (xx)
GR (1) GR871209B (xx)
HU (1) HU203106B (xx)
IL (1) IL83156A (xx)
IT (1) IT1228437B (xx)
NL (1) NL8701938A (xx)
NO (1) NO168530C (xx)
PL (1) PL154258B1 (xx)
PT (1) PT85656B (xx)
SE (1) SE8703343L (xx)
SU (1) SU1565346A3 (xx)
YU (1) YU46068B (xx)
ZA (1) ZA876657B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963547A (en) * 1988-06-01 1990-10-16 Smithkline Beecham Corporation Alpha-andrenergic receptor antagonists and use thereas
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
ES2057121T3 (es) * 1988-06-01 1994-10-16 Smithkline Beecham Corp Antagonistas de los receptores alfa-adrenergicos.
DE68919280T2 (de) * 1988-06-01 1995-03-23 Smithkline Beckman Corp Alpha-adrenergische Rezeptorantagonisten.
EP0344980A3 (en) * 1988-06-01 1991-05-15 Smithkline Beecham Corporation Alpha-adrenergic receptor antagonists
DE4102103A1 (de) * 1991-01-25 1992-08-20 Bayer Ag Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5248645A (en) * 1992-09-01 1993-09-28 Phillips Petroleum Company Ethylene oligomerization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124583A (en) * 1964-03-10 Substituted derivatives of
US3118900A (en) * 1962-01-15 1964-01-21 Abbott Lab Substituted derivatives of 3-aza-6, 7-benzo-8-oxa-5-phenylbicyclo[3.3.1]-nonane
US3401166A (en) * 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
US3446820A (en) * 1967-04-03 1969-05-27 Rexall Drug Chemical Substituted benzoxazocines and intermediates
US3869475A (en) * 1973-04-05 1975-03-04 Yissum Res Dev Co 2,6-methano-benzoxacin compounds
JPS50106985A (xx) * 1973-05-08 1975-08-22
US4100277A (en) * 1976-11-08 1978-07-11 American Home Products Corporation 4,1-Benzoxazonine derivatives and process therefor
ES8107211A1 (es) * 1979-08-09 1981-10-01 Glaxo Group Ltd Un procedimiento para la preparacion de nuevos derivados de benzoxocina.

Also Published As

Publication number Publication date
CN87106267A (zh) 1988-04-13
HU203106B (en) 1991-05-28
CH675723A5 (xx) 1990-10-31
IL83156A (en) 1992-12-01
GB8716668D0 (en) 1987-08-19
IL83156A0 (en) 1987-12-31
FI873852A0 (fi) 1987-09-07
DK464487D0 (da) 1987-09-07
ZA876657B (en) 1988-03-08
SE8703343D0 (sv) 1987-08-28
KR910002566B1 (ko) 1991-04-26
SU1565346A3 (ru) 1990-05-15
JPH0319236B2 (xx) 1991-03-14
CN1020103C (zh) 1993-03-17
DE3630539A1 (de) 1988-03-10
PL154258B1 (en) 1991-07-31
DD275052A1 (de) 1990-01-10
YU46068B (sh) 1992-12-21
BE1002121A4 (fr) 1990-07-17
FI873852A (fi) 1988-03-09
ATA185987A (de) 1994-05-15
FI88800B (fi) 1993-03-31
IT8721436A0 (it) 1987-07-24
PT85656A (en) 1987-10-01
NO873727L (no) 1988-03-09
FR2603587A1 (fr) 1988-03-11
JPS6377882A (ja) 1988-04-08
NO168530B (no) 1991-11-25
AU7816287A (en) 1988-03-10
FR2603587B1 (fr) 1991-02-01
PL267628A1 (en) 1989-06-12
GB2194786A (en) 1988-03-16
KR880003945A (ko) 1988-05-31
AU590443B2 (en) 1989-11-02
NL8701938A (nl) 1988-04-05
PT85656B (pt) 1990-05-31
NO168530C (no) 1992-03-04
DK464487A (da) 1988-03-09
CS621687A2 (en) 1990-09-12
NO873727D0 (no) 1987-09-07
US4859664A (en) 1989-08-22
IT1228437B (it) 1991-06-17
HUT50180A (en) 1989-12-28
ES2013322A6 (es) 1990-05-01
AR243190A1 (es) 1993-07-30
GR871209B (en) 1987-11-30
GB2194786B (en) 1991-01-02
FI88800C (fi) 1993-07-12

Similar Documents

Publication Publication Date Title
KR890005095A (ko) 신규 화합물들
DE69029334D1 (de) Verfahren zur Herstellung von Alkoxyiminoacetamid-Derivaten und ein Zwischenproduckt dafür
ATE50256T1 (de) Hypoglycemische thiazolidinedione.
NO823836L (no) Fremgangsmaate ved fremstilling av antifibrinolytisk aktive forbindelser.
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
FI894061A (fi) Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita
ATE285238T1 (de) Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl- phenol derivaten
SE8703343L (sv) Derivat av 2,3,4,5,6,7-hexahydro-2,7-metano-1,5-bensoxazonin (resp -1,4-bensoxazonin), forfarande for framstellning derav och lekemedel, som innehaller denna forening
IE780145L (en) Meta-sulphonamido-benzamides
ATE8144T1 (de) Indolobenzoxazine, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
ATE32900T1 (de) Methylendiphosphonsaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende antirheumatische arzneimittel.
SE9202476D0 (sv) Mellanprodukter foer framstaellning av epipodofyllotoxin och beslaektade foereningar och foerfaranden foer framstaellning och anvaendning daerav
ATE63746T1 (de) Thiophenderivat und verfahren zur herstellung.
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
DK511383D0 (da) Fremgangsmade til fremstilling af piperidindionderivater,der beskytter hjertemuskulaturen med en antiarythmisk aktivitet
ATE11915T1 (de) Benzothiazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung.
BR9801448B1 (pt) compostos heterocÍclicos, processo para sua preparaÇço e composiÇÕes farmacÊuticas contendo os mesmos.
ATE38665T1 (de) Verfahren zur herstellung von 5-perfluoralkyl-5,6-dihydrouracyl-derivaten und verwendbare zwischenprodukte.
DE3866292D1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE69011901D1 (de) 1-Arylsulfonyl-2-piperidinon-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen.
ATE31410T1 (de) Aryloxypropanolaminderivate, verfahren zu deren herstellung, pharmazeutische praeparate und therapeutische anwendung.
ATE56437T1 (de) Verfahren zur herstellung von 1,4dihydropyridinderivaten ueber neue zwischenprodukte.
SE8405429L (sv) Forfarande for framstellning av 7-acylindolin-2-oner
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
DK151332C (da) Analogifremgangsmaade til fremstilling af dibenzoxazonin-, dibenzoxazecin- eller dibenzoxaazacykloundecanderivater eller de tilsvarende thia- eller azaderivater eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8703343-7